Sign In  |  Register  |  About Santa Clara  |  Contact Us

Santa Clara, CA
September 01, 2020 1:39pm
7-Day Forecast | Traffic
  • Search Hotels in Santa Clara

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:

Dalrada Corporation Appoints Nick Gordon to Board of Directors

Dalrada Corporation (OTCQB: DFCO, "Dalrada"), an innovator in clean energy, healthcare, and technology, is pleased to announce the appointment of Nick Gordon to the Company's Board of Directors. Mr. Gordon, Senior Vice President of Institutional Investments at Millennium Commercial Properties, brings to Dalrada vast expertise in real estate investments trusts (REITs), real estate development, and capital growth.

"Nick's deep knowledge of the real estate and commercial business sectors greatly increases Dalrada's ability to expand our footprint in numerous market verticals, including clean energy adoption by the hospitality industry and commercial property sector. I'm excited to work with Nick, and I welcome him to our Board of Directors," said Dalrada's Chairman and CEO, Brian Bonar.

Mr. Gordon co-founded the real estate development and overseas trading companies Empire Commercial and Empire Trading International. He previously held positions as Managing Director of Forstmann & Co. and co-founded numerous companies, including Global Trust Group, a boutique private equity firm, and AMP Medical products. During his nearly 20-year career in sales and management, he has received numerous awards working for multi-billion-dollar companies like Eli Lilly, Medicis, Johnson & Johnson, and Mallinckrodt.

Tom Giles, President of Dalrada Energy Services, states, "Mr. Gordon's background with global REITs and property development enhances the benefits of implementing Environmental, Sustainability, and Governance (ESG) compliance through Dalrada's initiatives. His unique industry knowledge facilitates increased property values through Dalrada Energy Services' ESG offerings, as the Company enables substantial clean energy cost-savings across multiple industries."

While reduced dependence on CO2-producing fossil fuels occurs worldwide across multiple industries, Mr. Gordon's broad experience in the domestic and global petroleum markets, coupled with the introduction of new technology platforms, is a valuable asset to Dalrada Energy Services.

Dalrada Energy Services' (DES) comprehensive ESG compliance offerings include Dalrada's proprietary Likido®ONE heat pump technology powered by either sustainable or renewable energy sources. Likido® heat pumps boost energy efficiencies seven times more than traditional heat pumps and boilers and deliver as much as 75% cost savings over traditional fossil fuel sources.

In addition, DES' end-to-end ESG solutions upgrade existing properties or design new properties without capital outlay, leverage tax credits, significantly increase property values, and create new revenue streams that include carbon credits. These results enable property owners to achieve substantial cost savings and actualize new growth opportunities while "going green" through the adoption of ESG compliance.

Dalrada continuously creates innovative, impactful solutions to address the complex challenges of today and the future. To learn more about Dalrada Corporation, please visit www.Dalrada.com.

About Dalrada (DFCO)

Dalrada drives innovation that positively impacts people, businesses, and the planet. With subsidiaries that are firmly positioned in the world’s top three-growing industries of healthcare, clean energy, and technology, Dalrada creates solutions that are sustainable, affordable, and accessible.

The company works continually to produce disruptive products and services that accelerate positive change for current and future generations. Dalrada’s global solutions directly address climate change, post-pandemic gaps in the healthcare industry, and technology solutions for a new era of human behavior and interaction, ensuring a bright future for the world around us.

Established in 1982, Dalrada has since grown its footprint to include the unique business divisions: Dalrada Health, Dalrada Precision, and Dalrada Technologies. For more information, please visit www.dalrada.com.

Disclaimer

Statements in this press release that are not historical facts, the statements are forward-looking, including statements regarding future revenues and sales projections, plans for future financing, the ability to meet operational milestones, marketing arrangements and plans, and shipments to and regulatory approvals in international markets. Such statements reflect management's current views, are based on certain assumptions, and involve risks and uncertainties. Actual results, events, or performance may differ materially from the above forward-looking statements due to a number of important factors and will be dependent upon a variety of factors including, but not limited to, our ability to obtain additional financing that will allow us to continue our current and future operations and whether demand for our products and services in domestic and international markets will continue to expand. The Company undertakes no obligation to publicly update these forward-looking statements to reflect events or circumstances that occur after the date hereof or to reflect any change in the Company's expectations regarding these forward-looking statements or the occurrence of unanticipated events. Factors that may impact the Company's success are more fully disclosed in the Company's most recent public filings with the US Securities and Exchange Commission ("SEC"), including its annual report on Form 10-K.

Contacts

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
Copyright © 2010-2020 SantaClara.com & California Media Partners, LLC. All rights reserved.